Innovation
Innovation
Scaling the Biological Revolution
At Phagelux AgriHealth, we have bridged the gap between laboratory discovery and industrial-scale reality. While others study bacteriophages, we have built the global infrastructure to manufacture, stabilize, and deploy them at a scale that meets the demands of modern agriculture and food systems.
Overcoming the Barriers to Scale
Historically, the transition from lab to field was hindered by stability and production hurdles. We have solved these challenges through three core pillars of innovation:
Proprietary Stabilization Technology:
Unlike traditional biologicals, our cocktails are engineered for the real world. We utilize specialized matrices that preserve phage potency and extend shelf life under diverse storage and application conditions.
Custom Industrial Bioprocessing:
We moved beyond traditional fermentation to develop custom-designed bioreactor systems optimized specifically for phage yield and purity.
Precision Quality Assurance:
Our facilities utilize real-time analytical monitoring to ensure batch-to-batch consistency in concentration and infectivity—meeting the rigorous standards of global commercial supply chains.
Global Infrastructure
The Innovation Hubs
Our dual-continent operations allow us to lead the market through localized R&D and world-class manufacturing excellence in each location.
United States
Located in the U.S., our innovation and manufacturing hub focuses on phage discovery and manufacturing for the Americas. We have in-depth product design based on advanced genomic sequencing and phage development know-how, as well as advanced manufacturing techniques that promote efficiency as well as product stability.
This facility serves as the center for:
Rapid Discovery:
Identifying and optimizing new phages for emerging agricultural threats.
Regulatory Leadership:
Housing the teams that navigate complex global registrations and ensure EPA and USDA compliance.
Manufacturing Leadership:
The largest phage manufacturing facility in North America.
China
Our Chinese operations represent one of the most advanced phage R&D and manufacturing sites in Asia.
Large-Scale Production:
Equipped with industrial-scale bioreactor systems and packaging tools to meet the growing regional demand for sustainable solutions.
Regional Optimization:
Dedicated teams ensure our products are tailored to Asian agricultural systems and specific regional pathogen challenges.
A Future-Proof Pipeline
Innovation at Phagelux AgriHealth is a continuous cycle of improvement and expansion. Our strategic roadmap includes:
Broader Coverage:
Next-generation cocktail technologies that provide even wider pathogen protection with enhanced stability.
Sector Expansion:
Advancing solutions for poultry, swine, aquaculture, and emerging specialty crops.
Enhanced Delivery:
Investing in application systems that reduce costs for end-users while improving on-farm efficacy.
| Feature | Academic / Lab-Scale Research | Phagelux Industrial Manufacturing |
| Production Scale | Limited to small batches in flasks or pilot setups | Large-scale bioreactor systems producing tens of thousands of liters annually |
| Viability & Stability | Phages often lose potency quickly in simple buffers | Proprietary stabilization technologies and protective matrices ensure long-term shelf life |
| Quality Control | Manual, post-production checks for research purposes | Real-time advanced process control systems monitor critical parameters to ensure batch consistency |
| Contamination | High risk in standard laboratory environments | Multi-tiered sterile design and environmental monitoring specifically engineered for phage safety |
| Formulation | Liquid isolates used for immediate testing | Integrated formulations compatible with standard agricultural equipment and application systems |
| Regulatory | Focus on discovery and academic proof-of-concept | Comprehensive documentation and traceability for global market access and multi-jurisdictional compliance |
Learn More About Our Capabilities
